Toxicological Sciences 61, 49-53 (2001)
Copyright © 2001 by the Society of Toxicology
BIOTRANSFORMATION AND TOXICOKINETICS |
Characterization of Rat and Human UDP-Glucuronosyltransferases Responsible for the in Vitro Glucuronidation of Diclofenac
* Merck & Company, Department of Drug Metabolism, P.O. Box 2000, RY80-A9, Rahway, New Jersey 07065; and
University of Iowa, Department of Pharmacology, Iowa City, Iowa 52242
In the current study, the identification of the rat and human UDP-glucuronosyltransferase (UGT) isoforms responsible for the glucuronidation of diclofenac was determined. Recombinant human UGT1A9 catalyzed the glucuronidation of diclofenac at a moderate rate of 166-pmol/min/mg protein, while UGT1A6 and 2B15 catalyzed the glucuronidation of diclofenac at low rates (<20-pmol/min/mg protein). Conversely, human UGT2B7 displayed a high rate of diclofenac glucuronide formation (>500 pmol/min/mg protein). Recombinant rat UGT2B1 catalyzed the glucuronidation of diclofenac at a rate of 250-pmol/min/mg protein. Rat UGT2B1 and human UGT2B7 displayed a similar, low apparent Km value of <15 µM for both UGT isoforms and high Vmax values 0.3 and 2.8 nmol/min/mg, respectively. Using diclofenac as a substrate, enzyme kinetics in rat and human liver microsomes showed that the enzyme(s) involved in diclofenac glucuronidation had a low apparent Km value of <20 µM and a high Vmax value of 0.9 and 4.3 nmol/min/mg protein, respectively. Morphine is a known substrate for rat UGT2B1 and human UGT2B7 and both total morphine glucuronidation (3-O- and 6-O-glucuronides) and diclofenac glucuronidation reactions showed a strong correlation with one another in human liver microsome samples. In addition, diclofenac inhibited the glucuronidation of morphine in human liver microsomes. These data suggested that rat UGT2B1 and human UGT2B7 were the major UGT isoforms involved in the glucuronidation of diclofenac.
Key Words: acyl-glucuronides; UGTs; diclofenac; glucuronidation; NSAIDs.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Zhu, D. Bush, G. A. Doss, S. Vincent, R. B. Franklin, and S. Xu Characterization of 1'-Hydroxymidazolam Glucuronidation in Human Liver Microsomes Drug Metab. Dispos., February 1, 2008; 36(2): 331 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Fujiwara, M. Nakajima, H. Yamanaka, M. Katoh, and T. Yokoi Interactions between Human UGT1A1, UGT1A4, and UGT1A6 Affect Their Enzymatic Activities Drug Metab. Dispos., October 1, 2007; 35(10): 1781 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wen, D. E. Martin, P. Bullock, K.-H. Lee, and P. C. Smith Glucuronidation of Anti-HIV Drug Candidate Bevirimat: Identification of Human UDP-glucuronosyltransferases and Species Differences Drug Metab. Dispos., March 1, 2007; 35(3): 440 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Dean, S. Chang, M. V. S. Elipe, Y.-Q. Xia, M. Braun, E. Soli, Y. Zhao, R. B. Franklin, and B. Karanam Metabolism of MK-0524, a Prostaglandin D2 Receptor 1 Antagonist, in Microsomes and Hepatocytes from Preclinical Species and Humans Drug Metab. Dispos., February 1, 2007; 35(2): 283 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Takeda, Y. Kitajima, Y. Ishii, Y. Nishimura, P. I. Mackenzie, K. Oguri, and H. Yamada INHIBITION OF UDP-GLUCURONOSYLTRANSFERASE 2B7-CATALYZED MORPHINE GLUCURONIDATION BY KETOCONAZOLE: DUAL MECHANISMS INVOLVING A NOVEL NONCOMPETITIVE MODE Drug Metab. Dispos., August 1, 2006; 34(8): 1277 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xu, D. M. Krenitsky, A. M. Seacat, J. L. Butenhoff, T. R. Tephly, and M. W. Anders N-GLUCURONIDATION OF PERFLUOROOCTANESULFONAMIDE BY HUMAN, RAT, DOG, AND MONKEY LIVER MICROSOMES AND BY EXPRESSED RAT AND HUMAN UDP-GLUCURONOSYLTRANSFERASES Drug Metab. Dispos., August 1, 2006; 34(8): 1406 - 1410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tang and B. Ma GLYCOSIDATION OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST AND DICLOFENAC IN HUMAN LIVER MICROSOMES: AGLYCONE-DEPENDENT UDP-SUGAR SELECTIVITY Drug Metab. Dispos., December 1, 2005; 33(12): 1796 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Yan, J. Li, N. Huebert, G. W. Caldwell, Y. Du, and H. Zhong DETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDES Drug Metab. Dispos., June 1, 2005; 33(6): 706 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tachibana, M. Tanaka, Y. Masubuchi, and T. Horie ACYL GLUCURONIDATION OF FLUOROQUINOLONE ANTIBIOTICS BY THE UDP-GLUCURONOSYLTRANSFERASE 1A SUBFAMILY IN HUMAN LIVER MICROSOMES Drug Metab. Dispos., June 1, 2005; 33(6): 803 - 811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kaji and T. Kume REGIOSELECTIVE GLUCURONIDATION OF DENOPAMINE: MARKED SPECIES DIFFERENCES AND IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ISOFORM Drug Metab. Dispos., March 1, 2005; 33(3): 403 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Zhang, W. Zhao, V. A. Roongta, J. G. Mitroka, L. J. Klunk, and M. Zhu AMIDE N-GLUCURONIDATION OF MAXIPOST CATALYZED BY UDP-GLUCURONOSYLTRANSFERASE 2B7 IN HUMANS Drug Metab. Dispos., May 1, 2004; 32(5): 545 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Uchaipichat, P. I. Mackenzie, X.-H. Guo, D. Gardner-Stephen, A. Galetin, J. B. Houston, and J. O. Miners HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID Drug Metab. Dispos., April 1, 2004; 32(4): 413 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ghosal, N. Hapangama, Y. Yuan, J. Achanfuo-Yeboah, R. Iannucci, S. Chowdhury, K. Alton, J. E. Patrick, and S. Zbaida IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF EZETIMIBE (ZETIA) Drug Metab. Dispos., March 1, 2004; 32(3): 314 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Grillo, C. G. Knutson, P. E. Sanders, D. J. Waldon, F. Hua, and J. A. Ware STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE Drug Metab. Dispos., November 1, 2003; 31(11): 1327 - 1336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.M.J. van der Logt, H.M.J. Roelofs, F.M. Nagengast, and W.H.M. Peters Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens Carcinogenesis, October 1, 2003; 24(10): 1651 - 1656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Shelby, N. J. Cherrington, N. R. Vansell, and C. D. Klaassen Tissue mRNA Expression of the Rat UDP-Glucuronosyltransferase Gene Family Drug Metab. Dispos., March 1, 2003; 31(3): 326 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tang, J. H. Hochman, B. Ma, R. Subramanian, and K. P. Vyas Acyl Glucuronidation and Glucosidation of a New and Selective Endothelin ETA Receptor Antagonist in Human Liver Microsomes Drug Metab. Dispos., January 1, 2003; 31(1): 37 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kumar, K. Samuel, R. Subramanian, M. P. Braun, R. A. Stearns, S.-H. L. Chiu, D. C. Evans, and T. A. Baillie Extrapolation of Diclofenac Clearance from in Vitro Microsomal Metabolism Data: Role of Acyl Glucuronidation and Sequential Oxidative Metabolism of the Acyl Glucuronide J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 969 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Poon, Q. Chen, Y. Teffera, J. S. Ngui, P. R. Griffin, M. P. Braun, G. A. Doss, C. Freeden, R. A. Stearns, D. C. Evans, et al. Bioactivation of Diclofenac via Benzoquinone Imine Intermediates---Identification of Urinary Mercapturic Acid Derivatives in Rats and Humans Drug Metab. Dispos., December 1, 2001; 29(12): 1608 - 1613. [Abstract] [Full Text] [PDF]
|
|